MiR-145-5p was found to inhibit the growth of pancreatic cancer and angiogenesis in vivo by suppressing angiopoietin-2 (Wang et al., 2016), a critical regulator of tumor angiogenesis and progression (He et al., 2014). This evidence concerns the gene ANGPT2 and familial pancreatic carcinoma.